KCP expands research leadership team
The Kidney Cancer Program recently added two more distinguished members to its Scientific Advisory Board: Dr. E. Jason Abel with the University of Wisconsin School of Medicine and Public Health, and Dr. Brian Rini, Director of the Cleveland Clinic Cancer Center’s Genitourinary Cancer Program. Established in 2014, the advisory board comprises noted physicians and scientists from across the country who serve as a resource for KCP leadership.
UT Southwestern team develops novel imaging test to predict immunotherapy response in kidney cancer
Funding from the V Foundation and SPORE awards spurs development of a much needed immunotherapy biomarker for kidney cancer. In a proof-of-principle study, KCP investigators transform an immunotherapy drug into a diagnostic tracer to illuminate kidney tumors likely to benefit from checkpoint inhibitors. Press Release
Dr. Brugarolas named 2019 Robert F. Schnoes Lecture Series speaker
Dr. James Brugarolas was the honorary guest speaker for the University of Wisconsin-Madison’s 2019 Robert F. Schnoes Lecture Series. The annual event hosts prominent clinicians and researchers from around the country, sharing the latest cancer discoveries with faculty and residents of the UW Urology Program.
KCP hosts SPORE retreat with Dr. Brian Rini, Cleveland Clinic Cancer Center
The Kidney Cancer Program welcomed Dr. Brian Rini, Director of the Cleveland Clinic Cancer Center’s Genitourinary Cancer Program to a kidney cancer retreat at UT Southwestern to discuss collaborative research opportunities between the two programs.
Genentech-Roche conference spotlights latest research findings and treatment advancements
Members of the Kidney Cancer Program hosted a one-day retreat with scientists from Genentech-Roche to share research findings and discuss ongoing and future collaborations.
Dr. James Chen reports the near-atomic structure of STING, a key protein in innate immunity
Work from Dr. Zhijian "James" Chen's lab results in three published studies in Nature describing the near-atomic structure of STING, a key component of the innate immune system. This work could lead to improved immunotherapy approaches. Press Release
Dr. Andrew Koh receives inaugural KCP award to examine the gut microbiome in immunotherapy response
Dr. Andrew Koh, Associate Professor in the Department of Pediatrics, is the inaugural recipient of the Kidney Cancer Program's rolling funding opportunity, which offers grant support between $10K and $25K to investigators who have not previously received funding from the KCP or SPORE. Dr. Koh will investigate whether the gut microbiome plays a role in the response to checkpoint inhibitors in kidney cancer patients.
KCP/SPORE holds its External Advisory Board meeting
The KCP holds its External Advisory Board meeting, an important forum for updating our distinguished EAB members on the progress of the SPORE grant and the KCP, and for getting feedback and advice on the SPORE renewal.
KCP holds its 2nd annual Retreat for Trainees
The 2nd Annual KCP Retreat for Trainees was held at the A.W. Harris Faculty Club. This retreat is designed to encourage UTSW medical students, residents, and fellows to participate in a kidney cancer research project. The program features presentations by trainees who are currently doing research, early stage faculty who did research as trainees, resources available through the KCP, and grant opportunities.
Dr. Cadeddu receives the 2018 Patricia and William L. Watson Award for Excellence in Clinical Medicine
Dr. Jeffrey Cadeddu, Professor of Urology and Radiology,and Director, Clinical Center for Minimally Invasive Treatment of Urologic Cancer, receives the 2018 Patricia and William L. Watson Award for Excellence in Clinical Medicine. This annual award recognizes a UT Southwestern clinician whose work exemplifies a commitment to outstanding patient care and advancement of clinical innovations.